Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from SciSparc Ltd. ( (SPRC) ) is now available.
On June 25, 2025, SciSparc Ltd. convened its Annual General Meeting of Shareholders, which was adjourned to June 26, 2025, due to a lack of quorum. The adjourned meeting will allow any number of present shareholders to constitute a quorum, potentially impacting the company’s governance and decision-making processes.
More about SciSparc Ltd.
SciSparc Ltd. operates in the biotechnology industry, focusing on the development of cannabinoid-based therapies for various disorders. The company is based in Tel Aviv, Israel, and is involved in advancing treatments for conditions such as Tourette syndrome and Alzheimer’s disease.
Average Trading Volume: 2,057,086
Technical Sentiment Signal: Sell
Current Market Cap: $3.37M
For an in-depth examination of SPRC stock, go to TipRanks’ Overview page.